Nutrition support of blood or marrow transplant recipients: How much do we really know?

Practical Gastroenterology

Volumn 29, Issue 4, 2005, Pages 84-97

  Sheean, Patricia M ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; ENTERIC FEEDING; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; ISOGRAFT; MUCOSA INFLAMMATION; NUTRITIONAL REQUIREMENT; NUTRITIONAL SUPPORT; PATIENT CARE; RECIPIENT; REVIEW; TOTAL PARENTERAL NUTRITION;

EID: 17844401179     PISSN: 02774208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Osgoog EE, Riddle MC, Matthews TJ. Aplastic anemia treated with daily transfusion and intravenous marrow. Ann Intern Med, 1939;13:357-367.
2. Thomas ED, Lochte HL, Lu WC, Ferrebee JW. Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy. N Engl J Med, 1957;257:491-496.
3. Kurncisk NB, Feder BH, Montano A, Gerdes JC, Nakamura R. Some observations on the treatment of postirradiation hematopoietic depression in man by the infusion of stored autogenous bone marrow. Ann Intern Med, 1959;51:1204-1219.
4. Blood and Marrow Transplant Information Network. http://www.bmtnews.org Accessed January 2005.
5. International Bone Marrow Transplant Registry. http://www. ibmtr.org Accessed January 2005.
6. Armitage JO. Bone Marrow Transplant. N Engl J Med, 1994;330: 827-838.
7. Peters W, Hamm C, Baynes R. Principles of Bone Marrow Transplantation. In: Bast R, Kufe D, Pollock R, Weichselbaum R, Holland J, Frei E., eds. Cancer Medicine, 5th ed. Hamilton, Ontario, CA: B.C. Decker Incorporated, 2000.
8. American Cancer Society, http://www.cancer.org Accessed January 2005.
9. McCarthy PI, Williams LA. Stem Cell Transplantation: Past, Present, and Future. In: Buchsel P, Kapustay P., eds. Stem Cell Transplantation: A Clinical Textbook, 1st ed. Pittsburgh, PA: Oncology Nursing Society, 2000; 22-36.
10. Taveroff A, McArdle AH, Rybka WB. Reducing parenteral energy and protein intake improves metabolic homeostasis after bone marrow transplant. Am J Clin Nutr, 1991; 54:1087-1092.
11. Rapoport AP, Miller LF, Linder T, et al. Analysis of factors that correlate with mucositis in recipients of autologous and allogeneic stem cell transplants. J Clin Onc, 1999;17(8): 2446-2453.
12. Woo SB, Sonis ST, Monopoli MM, Sonis AL. A longitudinal study of oral ulcerative mucositis in bone marrow transplant recipients. Cancer, 1993;72:1612-1617.
13. Sacks GS, Ayinala S, Donelson SS, et al. Utilization of parenteral nutrition in patients receiving peripheral blood stem cell transplantation. J Miss State Med Assoc, 2000;41(5): 579-584.
14. Muscaritoli M, Grieco G, Capria S, Iori A, Rossi F. Nutritional and metabolic support in patients undergoing bone marrow transplantation. Am J Clin Nutr, 2002;75:183-190.
15. Bross DS, Tutschka PJ, Farmer ER, et al. Predictive factors for acute graft-versus-host disease in patients transplanted with HLA-identical bone marrow. Blood, 1984;63:1265-1270.
16. Flowers ME, Kansu E, Sullivan KM. Pathophysiology and Treatment of Graft-versus-Host Disease. Hematol Oncol Clin North Am, 1999;13(5):1091-1112.
17. Vogelsang GB. Chronic graft versus host disease. Br J Haematol, 2004;125:435-454.
18. Dean RM, Bishop MR. Graft-versus-host disease: emerging concepts in prevention and therapy. Curr Hematol Rep, 2003; 2(4):287-294.
19. Caudell KA. Graft-versus-host disease. In Whedon MB and Wujcik D, eds. Blood and Marrow Stem Cell Transplantation, Sudbury, MA: Jones and Bartlett, 1997: 177-204.
20. Przepiorka D, Ippolitis C, Koberda J, et al. Interleukin-2 for prevention of graft-versus-host disease after haploidentical marrow transplantation. Transplantation, 1994;58(7):858-860.
21. Storb R, Prentice RL, Hansen JA, et al. Association between HLA-B antigens and acute graft-versus-host disease. Lancet, 1983;2:816-819.
22. Wu D, Hockenbery DM, Brentnall TA, et al. Persistent nausea and anorexia after marrow transplantation. Transplantation, 1998;66(10):1319-1324.
23. Lee SJ, Barren AJ, Ringden O, et al. Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse. Blood, 2002;100:406-414.
24. Sullivan K, Agura E, Anasetti C. Chronic graft versus host disease in other late complications of bone marrow transplantation. Semin Hematol, 1991;28:250-259.
25. Centers for Disease Control. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. www.cdc.gov/mmwr/mmwr_rr.html MMWR RR-10: 49, 2000.
26. Lenssen P, Sherry ME, Cheney CL, et al. Prevalance of nutrition-related problems among long-term survivors of allogeneic marrow transplantation. J Am Diet Assoc, 1990;90:835-842.
27. Weisdorf S, Hofland C, Sharp HL, et al. Total parenteral nutrition in bone marrow transplantation: a clinical evaluation. J Pediatr Gastroenteral Nutr, 1984;3:95-100.
28. Hermann VM, Petruska P. Nutrition support in bone marrow transplant recipients. Nutr Clin Pract, 1993;8(1):19-27.
29. Szeluga DJ, Stuart RK, Brookmeyer R, et al. Energy requirements of parenterally fed bone marrow transplant recipients. J Parenter Enteral Nutr, 1985;9:139-143.
30. Szeluga DJ, Stuart RK, Brookmeyer R, et al. Nutritional support of bone marrow transplant recipients: a prospective, randomized clinical trial comparing total parenteral nutrition to an enteral feeding program. Cancer Res, 1987;47:3309-3316.
31. Cogoluenhes VC, Chambrier C, Michallet, et al. Energy expenditure during allogeneic and autologous bone marrow transplantation. Clin Nutr, 1998;17(6):253-257.
32. Schulte C, Reinhardt W, Beelen D, Schaefer U. Low T3-syndrome and nutritional status as prognostic factors in patients undergoing bone marrow transplantation. Bone Marrow Transplant, 1998;22:1171-1178.
33. Dezenhall A, Curry-Bartley K, Blackburn S, et al. Food and nutrition services in bone marrow transplant centers. J Am Diet Assoc, 1987;879(10):1351-1353.
34. Gauvreau-Stern JM, Cheney CL, Aker SN, Lenssen P. Food intake patterns and food service requirements on a marrow transplant unit. J Am Diet Assoc, 1989; 89(3):367-372.
35. Moody K, Charlson ME, Finlay J. The neutropenic diet- what's the evidence? J Ped Hemat Onc, 2002;24(9):717-721.
36. Todd J, Schmidt M, Christain J, Williams R. The low-bacteria diet for immunocompromised patients. Reasonable prudence or clinical superstition? Cancer Pract, 1999;7(4):205-207.
37. Smith LH, Besser SG. Dietary restrictions for patients with neutropenia: a survey of institutional practices. Oncol Nurs Forum, 2000;27(3):515-520.
38. Calvo V, Gonzalez P, Alaguero M, Perez-Simon JA. Intensive monitoring program for oral food intake in patients undergoing allogeneic hematopoietic cell transplantation: a cost-benefit analysis. Nutrition, 2002;18(9):769-771.
39. Charuhas PM, Fosberg KL, Bruemmer B, et al. A double-blind randomized trial comparing outpatient parenteral nutrition with intravenous hydration: effect on resumption of oral intake after marrow transplantation. J Parenter Enteral Nutr, 1997;21(3):157-161.
40. Stern JM, Bruemmer B, Moinpour CM, et al. Impact of a randomized, controlled trial of liberal vs conservative hospital discharge criteria on energy, protein, and fluid intake in patients who received marrow transplants. J Am Diet Assoc, 2000;100(9): 1015-1022.
41. Braunschweig CA, Levy P, Sheean P, Wang X. Enteral compared with parenteral nutrition: a meta-analysis. Am J Clin Nutr, 2001;74(4):534-542.
42. Mulder PO, Bouman JG, Gietema JA, et al. Hyperalimentation in autologous bone marrow transplantation for solid tumors. Comparison of total parenteral versus partial parenteral plus enteral nutrition. Cancer, 1989;64(10):2045-2052.
43. Sefcick A, Anderton D, Byrne JL, et al. Naso-jejunal feeding allogeneic bone marrow transplant recipients: results of a pilot study. Bone Marrow Transplant, 2001;28:1135-1139.
44. Weisdorf SA, Lysne J, Wind D, Haake RJ, Sharp HL, Goldman A, Schissel K, McGlave PB, Ramsay NK, Kersey JH. Positive effect of prophylactic total parenteral nutrition on long-term outcome of bone marrow transplantation. Transplantation, 1987;43:833-838.
45. Cetin T, Arpaci F, Dere Y, Turan M, Ozturk B, Komurcu S, Ozet A, Beyzadeoglu M, Kaptan K, Beyan C, Yalcin A. Total parenteral nutrition delays platelet engraftment in patients who undergo autologous hematopoietic stem cell transplantation. Nutrition, 2002;18:599-603.
46. Ziegler TR, Young LS, Benfell K, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. Annals of Internal Medicine, 1992;116:821-828.
47. MacBurney M, Young LS, Ziegler TR, Wilmore DW. A cost-evaluation of glutamine-supplemented parenteral nutrition in adult bone marrow transplant patients. J Amer Diet Assoc, 1994;94(11):1263-1266.
48. Schloerb PR, Skikne BS. Oral and parenteral glutamine in bone marrow transplantation: a randomized, double-blind study. J Parenter Enteral Nutr, 1999;23(3):117-122.
49. Lenssen P, Bruemmer BA, Bowden RA, et al. Intravenous lipid dose and incidence of bacteremia and fungemia in patients undergoing bone marrow transplantation. Am J Clin Nutr, 1998;67:927-933.
50. Muscaritoli M, Conversano L, Torelli GF. Clinical and metabolic effects of different parenteral nutrition regimens in patients undergoing allogeneic bone marrow transplantation. Transplantation, 1998;66:610-616.
51. Jansen J, Thompson JM, Dugan MJ, Nolan P, Wiemann M, Birhiray R, Henslee-Downey P, Akard L. Peripheral blood progenitor cell transplantation. Therapeutic Apheresis, 2002;6:5-14.
52. Iestra JA, Fibbe WE, Zwinderman AH, et al. Parenteral nutrition following cytotoxic therapy: an exploratory study on the need for parenteral nutrition after various treatment approaches for haematological malignancies. Bone Marrow Transplant, 1999;23:933-939.
53. Muscaritoli M, Grieco G, Capria S, Iori A, Rossi F. Nutritional and metabolic support in patients undergoing bone marrow transplantation. Amer J Clin Nutri, 2002;75:183-190.
54. Koretz RL, Lipman TO, Klein S. AGA Technical Review on Parenteral Nutrition. Gastroenterology, 2001;121:970-1001.
55. Van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in critically ill patients. New Engl J Med, 2001; 345: 1359-1367.
56. Krinsley JS. Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc, 2003;78(12):1471-1478.
57. Rowe JM, Ciobanu N, Ascensao J, et al. Recommended guidelines for the management of autologous and allogeneic bone marrow transplantation: a report from the Eastern Cooperative Oncology Group. Ann Intern Med, 1994;120(2):143-158.
58. Alexander A, Wong S. Graft versus host disease-pathophysiology and management, www.dcmsonline.org/jax-medicine/2000jour-